Key result
Positive tilt testing is linked to an ~88% drop in plasma ADMA in vasovagal syncope.
Why the study?
Vasovagal syncope has multiple pathophysiological mechanisms and asymmetric dimethylarginine (ADMA) is the major inhibitor of nitric oxide, prompting investigation into the relationship between plasma ADMA levels and syncope during head-up tilt testing.
Do plasma ADMA levels change during a head-up tilt test in patients with vasovagal syncope?
Cohort (n=97)
No
Do plasma ADMA levels change during a head-up tilt test in patients with vasovagal syncope?
Plasma ADMA levels significantly decrease during a positive head-up tilt test in patients with vasovagal syncope, suggesting a role for the nitric oxide pathway in its pathophysiology.
Answers are grounded in this paper and cite their sources.
ADMA reduction during positive tilt testing supports nitric oxide pathway involvement in vasovagal syncope; hypothesis-generating and requires prospective validation before clinical use.
Background and Objectives: Vasovagal syncope (VVS) is the most common cause of syncope and has multiple pathophysiological mechanisms. Asymmetric dimethylarginine (ADMA) is the major inhibitor of nitric oxide (NO). In this study, we aimed to investigate the relationship between plasma ADMA levels and syncope during the head-up tilt (HUT) test. Materials and Methods: Overall, 97 patients were included in this study. They were above 18 years of age and were admitted to our clinic with the complaint of at least one episode of syncope consistent with VVS. The HUT test was performed in all patients. Patients were divided into the following two groups based on the HUT test results: group 1 included 57 patients with a positive HUT test and group 2 included 35 patients with a negative HUT test. Blood samples were taken before and immediately after the HUT test to measure ADMA levels. Results: No significant intergroup differences were observed concerning gender and age (female gender 68% vs 60%; mean age 24.85 ± 4.01 vs 25.62 ± 3.54 years, respectively, for groups 1 and 2). ADMA values were similar between groups 1 and 2 before the HUT test [ADMA of 958 (544–1418) vs 951 (519–1269); p = 0.794]. In the negative HUT group, no significant differences were observed in ADMA levels before and after the HUT test [ADMA of 951 (519–1269) vs 951 (519–1566); p = 0.764]. However, in the positive HUT group, ADMA levels were significantly decreased following the HUT test [pretest ADMA of 958 (544–1418) vs post-test ADMA of 115 (67–198); p < 0.001]. Conclusion: ADMA levels significantly decreased after the HUT test in patients with VVS.
No takes yet. Share an insight, caveat, or question.
Atıcı et al. (2019) conducted a cohort in Vasovagal syncope (n=97). Positive head-up tilt (HUT) test (syncope occurrence) vs. Negative head-up tilt (HUT) test (no syncope) was evaluated on Plasma asymmetric dimethylarginine (ADMA) levels post-HUT test (p=<0.001). In patients with a history of vasovagal syncope, plasma ADMA levels decreased from a median of 958 to 115 following a positive head-up tilt test.
Synapse has enriched 10 related papers. Consider them for comparative context: